Bicara Therapeutics Inc.(BCAX)
$10.11-0.42 (-3.99%)
BCAX
Bicara Therapeutics Inc. earnings date
$10.11
At close:-0.42 (-3.99%)
Want to see BCAX full AI Analyst Report?
Bicara Therapeutics Inc. (BCAX) Q2 2025 Earnings Report
94 Followers
BCAX Q2 2025 EPS Results
- Actual EPS
- -$0.50
- Consensus EPS
- -$0.55
- Beat/Miss
- Beat by +$0.05
- One Year Ago EPS
- -$0.45
BCAX Q2 2025 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/12/2025
- Time
- Before Open
- Conference Call
- Tuesday, August 12, 2025
BCAX Upcoming Earnings
Bicara Therapeutics Inc.'s next earnings date is estimated for April 1, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
BCAX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | -1.04- | -0.93 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.82-1.04 | -0.67 | -55.22% (-0.37) | |
| Aug 11, 2026 | 2026 (Q2) | -0.82-0.82 | -0.5 | -64.00% (-0.32) | |
| May 11, 2026 | 2026 (Q1) | -0.65-0.93 | -0.68 | -36.76% (-0.25) | |
| Mar 30, 2026 | 2025 (Q4) | -0.67-0.68 | -0.39 | -74.36% (-0.29) | |
| Nov 18, 2025 | 2025 (Q3) | -0.54-0.67 | -1.6 | 58.13% (+0.93) | |
| Aug 12, 2025 | 2025 (Q2) | -0.55-0.50 | -0.45 | -11.11% (-0.05) | |
| May 13, 2025 | 2025 (Q1) | -0.41-0.68 | ― | ― | |
| Mar 27, 2025 | 2024 (Q4) | -0.33-0.39 | ― | ― | |
| Nov 12, 2024 | 2024 (Q3) | -0.41-1.60 | -0.42 | -280.95% (-1.18) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
